ipratropium bromide/salbutamol cipla 0,5 mg/2,5 mg per 2,5 ml nebuliser solution
cipla europe nv - Ипратропия бромид, Салбутамол - 0,5 mg/2,5 mg per 2,5 ml nebuliser solution
broncholytin 5,75 mg/4,6 mg/5 ml syrup
Софарма АД - Производни на опиум и отхаркивающие - 5,75 mg/4,6 mg/5 ml syrup
bronchocin 5,75 mg/4,60 mg/5 ml syrup
Актавис ЕАД - Производни на опиум и отхаркивающие - 5,75 mg/4,60 mg/5 ml syrup
tussirol 2,5 mg/1 mg/125 mg/ml syrup
Актавис ЕАД - Производни на опиум и отхаркивающие - 2,5 mg/1 mg/125 mg/ml syrup
favynd 18 micrograms inhalation powder, hard capsule
boehringer ingelheim international gmbh - Бромид tiotropium - 18 micrograms inhalation powder, hard capsule
srivasso 18 microgram inhalation powder, hard capsule
boehringer ingelheim international gmbh - Бромид tiotropium - 18 microgram inhalation powder, hard capsule
spiolto respimat 2,5 microgram/2,5 microgram inhalation solution
boehringer ingelheim international gmbh - olodaterol и бромид tiotropium - 2,5 microgram/2,5 microgram inhalation solution
yanimo respimat 2,5 microgram/2,5 microgram inhalation solution
boehringer ingelheim international gmbh - olodaterol и бромид tiotropium - 2,5 microgram/2,5 microgram inhalation solution
enteroporc coli ac
ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - Прасета - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:- clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6- clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins- clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.
suiseng diff/a
laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - Прасета - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.